国家科技部中国科技论文统计源期刊   中国科技核心期刊   WHO西太平洋地区医学索引(WPRIM)收录期刊   湖北优秀期刊
《药物流行病学杂志》官方网站与投审稿系统变更通知<点击查看详情>
神经节苷脂注射液7例聚集性不良反应分析
Analysis of 7 Aggressive Cases of Adverse Reaction of Monosialotetrahexosylganglioside Sodium Injection
  
DOI:
中文关键词:  神经节苷脂注射液  聚集性不良反应  影响因素  药物警戒
英文关键词:Monosialotetrahexosylganglioside sodium injection  Aggressive adverse reaction  Influence factors  Pharmacovigilance
基金项目:
作者单位
付海申 开封市中医院(河南开封 475000) 
韩方方 开封市中医院 
曹琳洁 开封市中医院 
摘要点击次数: 1069
全文下载次数: 967
中文摘要:
      摘 要 目的:分析神经节苷脂钠注射液出现聚集性不良反应的影响因素。方法:调阅本院ADR/ADE 监测系统内的7份神经节苷脂注射液聚集性不良反应记录及相关病历,对用药人群、使用环节、ADR症状等因素进行调查分析。结果:经质量检验,此次使用的神经节苷脂注射液为合格药品,此次聚集性不良反应表现为抽搐、寒战、发热等过敏样症状。7例聚集性不良反应的发生时间、溶媒选择、药物用量、滴速等因素基本相同,仅在溶媒用量、合并用药方面存在差异。结论:导致聚集性不良反应发生的影响因素很多,难以确定某个具体因素。聚集性ADR一旦发现,应立即停药,及时上报,寻找原因,推动药品质量不断提高和临床用药不断规范。
英文摘要:
      ABSTRACT Objective:To analyze the influence factors in 7 aggressive cases of adverse reaction of monosialotetrahexosylganglioside sodium injection. Methods:7 cases of patients treated with monosialotetrahexosylganglioside sodium injection and occurred adverse reaction were investigated in the ADR/ADE monitoring system in our hospital and the population treated with the drug, clinical using process, the symptoms of adverse reaction were comparatively analyzed in order to find the inductive factors of the aggressive adverse reaction. Results:By the state quality inspection, the monosialotetrahexosylganglioside sodium injection was qualified. The aggregation of adverse reactions leading by the monosialotetrahexosylganglioside sodium injection showed convulsions, chills, fever and other symptoms of allergy. The occurrence time, solvent selection, dosage, dropping speed and other factors of 7 cases aggregation adverse reaction were basically the same, only in the amount of solvent and combined use of drugs were difference. Conclusion:There were many factors that could cause the aggressive adverse reaction, and it was difficult to determine the specific factors. Therefore, once the aggressive adverse reaction were found, the drug should be stopped immediately, timely reporting and finding the reasons, to improve the drug quality and promote clinical drug regulation.
查看全文  查看/发表评论  下载PDF阅读器
关闭